• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Gilead to acquire stake in Tizona Therapeutics for $300n pharmaceutical-technology
    July 23, 2020
    Gilead Sciences is set to acquire a 49.9% equity interest in cancer immunotherapies maker Tizona Therapeutics through an investment of $300m.
  • Tizona Therapeutics appoints Scott Clarke as CEO biospectrumasia
    January 07, 2019
    US based biotech company, Tizona Therapeutics has announced that Scott Clarke has joined the company as its chief executive officer. Clarke joins from Roche where he served as the Global Head of Oncology Partnering and Head of Asia 。。。

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service